SiREM was founded in 2001 with the mission of bringing to market unique, science-based products and solutions in support of groundwater remediation. Our clients range from local to international environmental consulting firms, industry, academia, military and government. Our "client,first" philosophy surrounds every project and test we provide to give unbiased, high quality service and technical support. We focus on chlorinated solvents, perchlorate and other recalcitrant chemicals. Currently we offer bioremediation, nano-scale/zero-valent iron and chemical oxidation treatability studies, molecular genetic assays for dechlorinating bacteria, bioaugmentation cultures and products and services related to in situ chemical oxidation. Through our continued focus and support of research and development we strive to continually improve SiREM's current capabilities and to bring novel products and services to the remediation industry.
Lab21 is a leading provider of cutting edge diagnostics, supporting drug discovery, healthcare and environmental monitoring. Its customers include healthcare providers, pharmaceutical and biotechnology companies in addition. The Company supports organisations that need to monitor their impact on the environment. Lab21 has a rapidly growing portfolio of diagnostics to support early stage drug development, clinical trials and regulatory processes in the pharmaceutical industry. A key function is the support of clinicians and healthcare providers as they treat and monitor patients. The company's products include diagnostic tests for cancer, liver disease, respiratory illnesses and infectious diseases such as syphilis through its subsidiary Newmarket Laboratories. Its pharmaceutical support services which focus on anti-viral programmes include lead identification and optimisation of targets, drug resistance profiling, mode of action studies, and drug combination studies as well as clinical trial support. The Lab21 group includes MTI (Monitoring Technologies International), a company specialising in the development of environmental monitoring instruments, and Newmarket Laboratories, which specialises in the development and production of high-quality immunodiagnostics for infectious diseases.
OPTIGEN is a service company established to provide DNA based diagnoses and information about inherited diseases of dogs. We promise the highest quality diagnostic and testing services available in the fields of veterinary medical genetics and molecular diagnostics. Our testing procedures are developed by research scientists and veterinarians associated with OPTIGEN, and are extensively field-tested in cooperation with breeders of dogs. At OPTIGEN, our only standard is excellence. Who we are ... OPTIGEN'S strength is based on research and experience. Our founding members have collaborated for decades on projects in the fields of veterinary ophthalmology, molecular diagnostics, and genetics. Veterinary ophthalmologists Gregory Acland and Gustavo Aguirre have gained international recognition for their award-winning work. They have a wide range of experience with the problems and challenges faced by dog owners and breeders. Jeanette Felix, geneticist, has administered research grants for human inherited retinal disease studies and currently manages OptiGen. What we offer ... OPTIGEN provides the highest diagnostic accuracy available, minimum turn-around time for report and interpretation, and full confidentiality. Each test is read independently by two staff scientists. Our interpretive report and website pages include information on: - preventing genetic disease - how to safely eliminate undesired genes from breeding stock - how to maintain desired breeding lines if critical dogs are carriers or even affected - trends in disease frequency derived from our database In addition, OPTIGEN offers to archive DNA samples-meaning that, most likely, breeders won't need to supply a second DNA sample for future tests as they become available. Our genetic testing, counseling and data-base services promise the ultimate genetic advantage for your breeding program. What we provide ...
Myriad Genetic Laboratories, Inc. is a biopharmaceutical company that focuses on developing new therapeutic and predictive medicine products. Myriad Genetic Laboratories uses innovative technology to perform genetic testing of the highest quality available. Myriad identifies genes, related proteins and biological pathways, and then uses this information to predict a person's risks of developing specific cancers. Myriad's genetic testing helps people and their doctors work together to more effectively prevent and fight cancer.
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory